What is LifeMD, Inc. (LFMD) stock price today?

LifeMD, Inc. (LFMD) is currently trading at $2.63, down 0.75% today.

What is LFMD P/E ratio?

LifeMD, Inc.'s P/E ratio is -5.39. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is LFMD return on equity (ROE)?

LifeMD, Inc.'s return on equity (ROE) is -179.12%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is LifeMD, Inc.'s market cap?

LifeMD, Inc. has a market capitalization of $127.19M.

NASDAQ · Medical - Pharmaceuticals

LifeMD, Inc. (LFMD) Stock

$2.63 -0.75% NASDAQ: LFMD Healthcare

Valuation

Metric	Value
Price	$2.63
Market Cap	$127.19M
P/E Ratio	-5.39
P/B Ratio	16.44
P/S Ratio	0.65
EPS (TTM)	$-0.23
52-Week High	$7.32
52-Week Low	$2.56
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-179.12%
ROA	-35.50%
ROCE	-143.97%
Gross Margin	-4.12%
Operating Margin	-4.12%
Net Margin	-10.40%
Debt/Equity	0.76
Current Ratio	1.24

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$93.0M	$119.0M	$153.0M	$212.0M	$194.0M
Operating Profit	$-54.0M	$-43.0M	$-14.0M	$-16.0M	$-8.0M
Net Profit	$-61.0M	$-46.0M	$-21.0M	$-19.0M	$-7.0M
EPS	$-2.27	$-1.57	$-0.70	$-0.53	$-0.23
Op Margin	-58.5%	-36.5%	-9.5%	-7.6%	-4.0%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$50.0M	$26.0M	$58.0M	$72.0M	$70.0M
Total Liabilities	$24.0M	$33.0M	$53.0M	$77.0M	$47.0M
Cash	$41.0M	$4.0M	$33.0M	$35.0M	$37.0M
Borrowings	$2.0M	$4.0M	$19.0M	$25.0M	$6.0M

Latest News

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock GlobeNewswire · Jun 23, 2026 LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection GlobeNewswire · Jun 22, 2026 CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last? Zacks · Jun 19, 2026 How The Story Is Evolving For LifeMD (LFMD) With An Unchanged Fair Value View Simply Wall St. · Jun 4, 2026 LifeMD Names Umesh Sripad as Chief Technology Officer MT Newswires · Jun 1, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-33.0M	$-23.0M	$9.0M	$18.0M	$8.0M
Investing Cash Flow	$-7.0M	$-27.0M	$-17.0M	$-23.0M	$-3.0M
Financing Cash Flow	$1.0M	$0	$-1.0M	$-1.0M	$-1.0M
Net Cash Flow	$32.0M	$-37.0M	$29.0M	$2.0M	$2.0M
Free Cash Flow	$-36.0M	$-36.0M	$0	$6.0M	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.05
EV / EBITDA	-8.58
FCF Yield	-5.42%
Quick Ratio	0.84
Interest Coverage	-72.87
Return 1Y	-60.16%
Return 3Y	10.00%
Return 5Y	-52.63%

Ownership

Insiders Held13.91%

Institutions Held40.88%

Institutions Float Held47.49%

Institutional Holder	Shares	Report Date
Blackrock Inc.	2,809,025	2026-03-31
Vanguard Capital Management LLC	1,663,696	2026-03-31
Royce & Associates LP	1,201,651	2026-03-31
Renaissance Technologies, LLC	1,118,325	2026-03-31
State Street Corporation	1,075,408	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CERSCerus Corporation	$2.30	+0.88%	-62.98	$463.51M	0.00%
CVRXCVRx, Inc.	$1.58	-5.95%	-0.78	$41.93M	0.00%
HITIHigh Tide Inc.	$2.61	+1.16%	-9.88	$229.34M	0.00%
MASS908 Devices Inc.	$12.05	+4.33%	-13.65	$494.38M	0.00%
OMIOwens & Minor, Inc.	$2.68	+8.94%	14.39	$207.07M	0.00%

About LifeMD, Inc.

LifeMD, Inc. is led by CEO Justin Schreiber, publicly traded since 2008.

LifeMD, Inc. (LFMD) stock trades at $2.63 with a market capitalization of $127.19M. The stock is valued at a price-to-earnings (P/E) ratio of -5.39, price-to-book of 16.44, price-to-sales of 0.65. Over the past 52 weeks the stock has ranged between $2.56 and $7.32, and currently trades 64.1% below its 52-week high.

On profitability, LifeMD, Inc. generates a return on equity (ROE) of -179.12%, return on capital employed of -143.97%, an operating margin of -4.12%, a net profit margin of -10.40%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides